No Data
No Data
Bell Potter Names the Best ASX Retail Stocks to Buy in FY25
PMV Pharmaceuticals to Participate at Upcoming Investor Conferences in June
Buy Rating on PMV Pharmaceuticals: Strategic Partnerships and Promising Clinical Pipeline Underpin Positive Outlook
Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective P53 Y220C Reactivator
Analysts Offer Insights on Healthcare Companies: PMV Pharmaceuticals (PMVP) and Phathom Pharmaceuticals (PHAT)
PMV Pharmaceuticals Initiated at Buy by Craig-Hallum